Coya Therapeutics, Inc. Common Stock (COYA)
Coya Therapeutics, Inc. (COYA) is a biopharmaceutical company focused on developing therapies for neurodegenerative and neuroinflammatory diseases. The company leverages cell-based and immunomodulatory approaches to address conditions such as amyotrophic lateral sclerosis (ALS) and other neurological disorders. Coya aims to advance innovative treatments that can modify disease progression and improve patient outcomes.
Company News
Dr. Reddy's (RDY) enters into a licensing agreement with Coya Therapeutics to develop and commercialize the latter's ALS investigational combination therapy, COYA 302.
We've compiled a list of August investment picks that you may have missed. Some Seeking Alpha analysts are more discerning by nature. See their Buy recommendations here.
Within the last quarter, Coya Therapeutics (NASDAQ:COYA) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 8 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 3 0 0 0 0 3M Ago 4 0 0 0 0 According to 8 analyst offering 12-month price targets in the last 3 mo...